Desk› Healthcare› Rekvina Laboratories Ltd
Rekvina Laboratories Ltd
Filing rhythm · 60 trading days
17 filings · 3 material · busiest 2026-06-30
What it files
Filings
17 in the window
-
18 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Surbhit Mukesh Shah & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 August 2026
SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruvalkumar Patel
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
GeneralClarification On Price Movement
Clarification on Price Movement
Company Update / General View filing →
-
13 August 2026
Board OutcomeBoard Meeting Outcome for OUTCOME OF BOARD MEETING
OUTCOME OF BOARD MEETING
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026
-
12 August 2026
AllotmentAllotment
Allotment of Equity Shares on Preferential basis
Company Update / Allotment of Equity Shares View filing →
-
12 August 2026
ClarificationClarification sought from Rekvina Laboratories Ltd
The Exchange has sought clarification from Rekvina Laboratories Ltd on August 12, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Company Update / Clarification
-
31 July 2026
GeneralPost Offer Advertisement
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulation 18(12) of the Securities Exchange Board ....
Company Update / General View filing →
-
15 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 June 2026
Trading WindowClosure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
30 June 2026
GeneralPre-Offer Advertisement & Corrigendum to Detailed Public Statement
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange ....
Company Update / General View filing →
-
30 June 2026
Open Offer UpdateOpen Offer - Updates
Open Offer Update
Company Update / Open Offer - Updates View filing →
-
25 June 2026
Open Offer UpdateOpen Offer - Updates
Newspaper Advertisement
Company Update / Open Offer - Updates View filing →
-
25 June 2026
Open OfferUpdates on Open Offer
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors in accordance with Regulation 26(7) ....
Company Update / Open Offer View filing →
-
24 June 2026
Open Offer UpdateOpen Offer - Updates
Recommendations of the Committee of Independent Directors of Company under Regulation 26(7) of SEBI (SAST) Regulation, 2011
Company Update / Open Offer - Updates View filing →
-
23 June 2026
GeneralLetter of Offer
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Rekvina Laboratories Ltd ("'Target ....
Company Update / General View filing →
-
23 June 2026
Open Offer UpdateOpen Offer - Updates
We wish to inform you that the company has received a copy of the letter of offer issued by Vivro Financial Services Private Limited in relation to open offer to the Public Shareholders.
Company Update / Open Offer - Updates View filing →